- HIMS +3.12%
Evaluating the Investment Potential of Hims & Hers
Yahoo Finance · 4 hours ago
Open | 23.70 |
High | 24.42 |
Low | 23.24 |
Mkt Cap | 5.25B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 23.68 |
52 Wk. Low | 5.65 |
52 Wk. High | 24.42 |
Related stocks
American telehealth company
Hims & Hers Health, Inc. is an American telehealth company that sells prescription and over-the-counter drugs online, as well as personal care products. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 278.17M | 45.80% ▲ |
Net Income | 11.13M | - |
Diluted EPS | 0.05 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.04 | - |
Q1 2024 | $0.01 | $0.05 |
Q4 2023 | -$0.02 | $0.01 |
S&P 500^GSPC | 5,426.61+5.58 (+0.10%) |
Dow 30^DJI | 38,623.42-88.79 (-0.23%) |
Nasdaq^IXIC | 17,649.14+40.71 (+0.23%) |
877.07+13.21% | |
Broadcom Inc.AVGO | 1,675.80+12.06% |
Longeveron Inc.LGVN | 3.1996+76.77% |